Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor-Induced Adrenal Insufficiency: A Case Report.
Saved in:
| Title: | Talimogene Laherparepvec Response in Recurrent Melanoma During Corticosteroid Replacement for Immune Checkpoint Inhibitor-Induced Adrenal Insufficiency: A Case Report. |
|---|---|
| Authors: | Sabetfakhri NN; University of Vermont Larner College of Medicine, Burlington, VT., Rehman HT; University of Vermont Larner College of Medicine, Burlington, VT.; Department of Medicine, Division of Hematology and Oncology, University of Vermont Medical Center, Burlington, VT., Cook DL; University of Vermont Larner College of Medicine, Burlington, VT.; Department of Pathology and Laboratory Medicine, UVMMC, Burlington, VT., Barrett KV; University of Vermont Larner College of Medicine, Burlington, VT.; Department of Medicine, Division of Endocrinology and Diabetes, UVMMC, Burlington, VT., Cintolo-Gonzalez JA; University of Vermont Larner College of Medicine, Burlington, VT.; Department of Surgery, Division of Surgical Oncology, University of Vermont Medical Center, Burlington, VT. |
| Source: | Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2026 Jun 08. Date of Electronic Publication: 2026 Jun 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1537-4513 |
|---|---|
| DOI: | 10.1097/CJI.0000000000000609 |
